AC Immune Reports Third Quarter 2016 Results
November 11, 2016 07:12 ET
|
AC Immune SA
LAUSANNE, Switzerland, Nov. 11, 2016 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ:ACIU), a Swiss-based, clinical stage biopharmaceutical company focused on neurodegenerative diseases, today announced...
AC Immune SA Reports Third Quarter 2016 Results
November 11, 2016 06:35 ET
|
AC Immune SA
AC Immune Reports Third Quarter 2016 Results Successfully Completed Initial Public Offering on NASDAQ, Net Proceeds of $ 70.5 million (CHF 69.4 million)* Lausanne, Switzerland,...
Switzerland's AC Immune Opens For Trading On NASDAQ
September 23, 2016 01:42 ET
|
AC Immune SA
SWITZERLAND'S AC IMMUNE OPENS FOR TRADING ON NASDAQ
LAUSANNE, Switzerland, Sept. 23, 2016 (GLOBE NEWSWIRE) -- AC Immune SA, a Swiss-based, clinical stage biopharmaceutical company focused on...
Switzerland's AC Immune Opens For Trading On NASDAQ
September 23, 2016 01:38 ET
|
AC Immune SA
SWITZERLAND'S AC IMMUNE OPENS FOR TRADING ON NASDAQ Lausanne, Switzerland, September 23, 2016 - AC Immune SA, a Swiss-based, clinical stage biopharmaceutical company focused on neurodegenerative...
AC Immune SA Announces Pricing of Upsized Initial Public Offering
September 22, 2016 18:21 ET
|
AC Immune SA
AC Immune Announces Pricing of Upsized Initial Public Offering Lausanne, Switzerland - September 23, 2016 - AC Immune SA announced today the pricing of its initial public offering of 6,000,000 of...
AC Immune SA Commences Proposed Initial Public Offering of Common Shares
September 13, 2016 16:53 ET
|
AC Immune SA
LAUSANNE, Switzerland, Sept. 13, 2016 (GLOBE NEWSWIRE) -- AC Immune SA announced today that it has commenced the initial public offering of 4,545,456 of its common shares pursuant to a registration...
AC Immune SA Commences Proposed Initial Public Offering of Common Shares
September 13, 2016 16:44 ET
|
AC Immune SA
AC Immune Commences Proposed Initial Public Offering of Common Shares Lausanne, Switzerland - September 13, 2016 - AC Immune SA announced today that it has commenced the initial public...